TARPLIN, DOWNS & YOUNG, LLC for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
**see addendum page ***, no specific bill, Raising Awareness of Hepatitis C, HHS National Strategy ***, no specific bill, public health funding for Hepatitis, appropriations for the Department of Health and Human Services, screening guidelines PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 1217 - to Repeal the Prevention and Public Health Fund.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Budget/Appropriations BUD
**see addendum page budget resolution, health care reform, prevention fund, debt ceiling negotiations H.R. 1473, Final Fiscal Year 2011 Continuing Resolution House Budget Resolution H.R. 1, Full-Year Continuing Appropriations Act, 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. On Finance; |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | Congressman Billy Tauzin |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.